Symbol="TCBP"
AssetType="Common Stock"
Name="TC BioPharm Holdings PLC"
Description="TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, is focused on developing immunotherapy products based on its gamma delta allogeneic T-cell platform. The company is headquartered in Motherwell, the United Kingdom."
CIK="1872812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, GB"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="2620400"
EBITDA="-11158647"
PERatio="None"
PEGRatio="None"
BookValue="-0.027"
DividendPerShare="0"
DividendYield="0"
EPS="-2.83"
RevenuePerShareTTM="5.59"
ProfitMargin="-0.361"
OperatingMarginTTM="-3.101"
ReturnOnAssetsTTM="-0.785"
ReturnOnEquityTTM="0"
RevenueTTM="3844500"
GrossProfitTTM="3844500"
DilutedEPSTTM="-2.83"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.886"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="84.97"
PriceToBookRatio="137.08"
EVToRevenue="84.78"
EVToEBITDA="-85.23"
Beta="None"
num_52WeekHigh="18"
num_52WeekLow="0.418"
num_50DayMovingAverage="0.548"
num_200DayMovingAverage="2.725"
SharesOutstanding="4688500"
DividendDate="None"
ExDividendDate="None"
symbol="TCBP"
open="0.51"
high="0.64"
low="0.50"
price="0.56"
volume="940990.00"
latest_trading_day="2023-08-29"
previous_close="0.56"
change="0.00"
change_percent="0.4473%"
aroon_positive_momentum_days="6"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="557606"
Change_recent_avg="-0.02"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="614"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
